Malaria vaccines–targeting infected hepatocytes (original) (raw)

• Daubersies, P. et al. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with a conserved pre-erythrocyte antigen, LSA-3. Nature Med. 6, 1258–1263 (2000).
  Article CAS Google Scholar
• Nussenzweig et al. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 216, 160–162 (1967).
  Article CAS Google Scholar
• Clyde, D. F. et al. Immunization of man against sporozoite-induced falciparum malaria. Am.J.Med.Sci. 266, 169– 177 (1973).
  Article CAS Google Scholar
• Rieckmann, K. H. et al. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull.World Health Organ. 57, 261–265 ( 1979).
  PubMed PubMed Central Google Scholar
• Doolan, D. L. & Hoffman, S.L. The complexity of protective immunity against liver-stage malaria. J Immunol. 165, 1453–1462 (2000).
  Article CAS Google Scholar
• Hoffman, S.L. et al. Attacking the infected hepatocyte. in Malaria Vaccine Development: A Multi-Immune Response Approach. (ed. Hoffman, S. L. Washington, DC) 35–75 (ASM Press, Bilthoven, The Netherlands, 1996).
  Google Scholar
• Stoute, J. A. et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N. Engl. J. Med. 336, 86–91 (1997).
  Article CAS Google Scholar
• Aidoo, M. et al. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. Infect. Immun. 68, 227–232 ( 2000).
  Article CAS Google Scholar
• Stoute, J. A. et al. Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. J. Infect. Dis. 178 , 1139–1144 (1998).
  Article CAS Google Scholar
• Lalvani, A. et al. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. J. Infect. Dis. 180, 1656 –1664 (1999).
  Article CAS Google Scholar
• Le, T. P. et al. Intramuscular administration of a malaria DNA vaccine is safe, well-tolerated and induces CTL, but not detectable antibodies, in healthy human volunteers. Vaccine 18, 1893– 1901 (2000).
  Article CAS Google Scholar
• Wang, R. et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282, 476 –480 (1998).
  Article CAS Google Scholar
• Hoffman, S. L. & Doolan, D. L. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization? in Development and Clinical Progress of DNA Vaccines (eds. Brown, F., Cichutek, R.& Robertson, J.) 104, 121–132 (Karger Publishers, Basel, 2000).
  Google Scholar
• Gilbert, S. C. et al. A protein particle vaccine containing multiple malaria epitopes . Nature Biotechnol. 15,1280– 1284 (1997).
  Article CAS Google Scholar
• Gardner, M. J. et al. Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Science 282, 1126– 1132 (1998).
  Article CAS Google Scholar
• Hoffman, S. L. et al. From genomics to vaccines: malaria as a model system. Nature Med. 4, 1351–1353 (1998).
  Article CAS Google Scholar
• Miller, L.H. & Hoffman, S.L. Research toward vaccines against malaria. Nature Med. 4, 520– 524. (1998).
  Article CAS Google Scholar